Abstract:Background There were no data about prevention and control status of RR-TB in a poor area with high burden of TB in China. In order to develop evidence-based RR-TB response strategies and improve enrollment of RR-TB patients in Yunnan province, China, this study was aimed at analyzing the changing trends in the detection and enrollment of RR-TB patients and examining the factors that may have implication on enrollment in treatment. Methods Data, which includes demographics, screening and testing, and treatment enrollment, was collected from the TB Management Information System. Retrospective data analysis and factors analysis were applied. Descriptive statistics, Chi-square test, Rank sum test and logistic regression analysis were used. Results From 2016 and 2018, the province had been challenged by low levels of screening, detection and enrollment of RR-TB. During the period between 2019 and 2020, a comprehensive model of RR-TB prevention and control was established in Yunnan, characterized by a robust patient-centered approach for RR-TB care and multiple, targeted interventions through the cascade of care from detection to treatment. In 2020, 93.8% of the bacteriologically positive TB patients were screened for RR-TB, which had been significantly increased by 146.9% from 38.0% in 2016. The interval from initial consultation at RR-TB facility to diagnosis (inter-quartile range) was reduced from 29.5 (1–118) days in 2016 to 0 (0–7) days in 2020. Despite the increasing rates of enrollment of RR-TB patients over the years, non-enrollment of those detected was still high (32.3%) in 2020. The main reasons for non-enrollment identified were refusal of treatment due to financial difficulties, loss to follow-up or death before starting treatment. Multivariate analysis showed that the elderly patients aged 65 or above (OR = 2.7, CI: 1.997–3.614), new patients (OR = 0.7, CI: 0.607–0.867), conventional DST used for confirmatory diagnosis of RR-TB (OR = 1.9, CI: 1.620–2.344) and diagnosis of RR-TB being conducted by the RR-TB care facilities at the prefecture and municipal level (OR = 4.4, CI: 3.608–5.250) have implications on RR-TB non-enrollment. Conclusions As a comprehensive RR-TB model was implemented in Yunnan with scaled up use of molecular test for rapid detection of RR-TB, initial screening of RR-TB were decentralized to the county- and district-level to strengthen rapid, early detection of RR-TB, achieving a higher coverage of screening in the end. However, there remains a major gap in enrollment of RR-TB. The main barriers include: limited knowledge and awareness of RR-TB and financial burdens among patients, delayed diagnosis, loss to follow-up, difficulties in self care and travel for elderly patients, and limited capacity of clinical management at the lower-level RR-TB care facilities. The situation of the RR-TB epidemic in Yunnan could be improved and contained as soon as possible by continuous strengthening of the comprehensive, patient-centered model with targeted interventions coordinated through multi-sectoral engagement to improve enrollment of RR-TB patients.

Analysis on progress of tuberculosis drug resistance baseline survey of Guangdong province

Longitudinal Molecular Epidemiological Study of Multidrug Resistant Tb and Transition to Extensively Drug Resistance in Eastern Rual China

The analysis of causes that result in re-treatment of drug-resistant tuberculosis in Zhejiang

Analysis of the Results of Tuberculosis Drug Resistance Surveillance in Yuexiu District, Guangzhou City, 2013–2022

Investigation for prognosis of hospitalized patients with pulmonary tuberculosis and analysis for related factors

Analysis of the change of the anti-TB drug resistance spectrum in last decade in Guangdong province

Short-course Regimen for Subsequent Treatment of Pulmonary Tuberculosis: A Prospective, Randomized, Controlled Multicenter Clinical Trial in China.

Changing trend analysis on early detection of rifampicin resistant tuberculosis patients in southwestern area of China, 2016–2020

The longitudinal trends of multidrug and extensively drug resistant tuberculosis in China

Drug Resistance of Tuberculosis Patients in Huizhou

Analysis of Drug Resistance and Mutation Profiles in Mycobacterium Tuberculosis Isolates in a Surveillance Site in Beijing, China.

Clinical analysis for the development of extensively drug-resistant tuberculosis in Chongqing,China

Research of TB Treatment Compliance and Socio!economic and Clinical Factors Influencing it in Guanyun County

Prevalence of Multidrug-Resistant Pulmonary Tuberculosis in Counties with Different Duration of Dots Implementation in Rural China

Monitoring result analysis on resistance of 87 cases of tubercle bacillus in Dali

Study on the drug resistance among treatment-experienced tuberculosis patients in Sichuan Province

Analysis on prevention and control project of tuberculosis casefinding in Baoji City

Comparison of three methods in the detection of tuberculosis and analysis of drug resistance in clinical isolates of Mycobacterium

Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China

[Evaluation of screening strategies of multidrug-resistant tuberculosis among pulmonary tuberculosis patients of the different risk levels]

Access to Bacteriologic-Based Diagnosis in Smear Positive Retreatment Tuberculosis Patients in Rural China: A Cross-Sectional Study in Three Geographic Varied Provinces.